Literature DB >> 28508374

AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study.

Nehme El-Hachem1, Benjamin Haibe-Kains2, Athar Khalil3, Firas H Kobeissy4,5, Georges Nemer6.   

Abstract

Computational docking and scoring techniques have revolutionized structural bioinformatics by providing unprecedented insights on key aspects of ligand-receptor interaction. Docking is used for optimizing known drugs and for identifying novel binders by predicting their binding mode and affinity. AutoDock and AutoDockTools are free of charge techniques that have been extensively cited in the literature as essential tools in structure-based drug design. Moreover, these methods are fast enough to permit virtual screening of ligand libraries containing tens of thousands of compounds. However using Autodock requires some knowledge in programming which creates a limitation for biologists and makes them prone for commercial applications. Here, we selected a relevant target involved in the progression of Alzheimer disease and provided a fully reproducible docking protocol. This example will show how docking techniques would be an important asset to identify new BACE1 inhibitors. The following friendly user tutorial targets both undergraduate and graduate students, allowing them to understand docking as a computational tool for structure-based drug design.

Entities:  

Keywords:  Alzheimer disease; AutoDock; BACE1; Docking

Mesh:

Substances:

Year:  2017        PMID: 28508374     DOI: 10.1007/978-1-4939-6952-4_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer's disease.

Authors:  Rayala Swetha; Anjali Sharma; Ravi Singh; Ankit Ganeshpurkar; Devendra Kumar; Ashok Kumar; Sushil K Singh
Journal:  Mol Divers       Date:  2022-08-06       Impact factor: 3.364

2.  Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification.

Authors:  Hui Jiang; Tangyou Mao; Yuyue Liu; Xiang Tan; Zhongmei Sun; Yuan Cheng; Xiao Han; Yang Zhang; Jiali Wang; Lei Shi; Yi Guo; Junxiang Li; Haixiao Han
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  Improving protein-ligand docking and screening accuracies by incorporating a scoring function correction term.

Authors:  Liangzhen Zheng; Jintao Meng; Kai Jiang; Haidong Lan; Zechen Wang; Mingzhi Lin; Weifeng Li; Hongwei Guo; Yanjie Wei; Yuguang Mu
Journal:  Brief Bioinform       Date:  2022-05-13       Impact factor: 13.994

4.  Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.

Authors:  Hyunjo Kim; Hyunwook Han
Journal:  Bioinformation       Date:  2018-05-05

5.  Biophysical Insight into the Interaction of Human Lysozyme with Anticancer Drug Anastrozole: A Multitechnique Approach.

Authors:  Fahad M Almutairi; Mohammad Rehan Ajmal; Adel Ibrahim Al Alawy; Rizwan Hasan Khan; Ali Saber Abdelhameed
Journal:  ScientificWorldJournal       Date:  2020-08-25

6.  Novel Carbazole-Piperazine Hybrid Small Molecule Induces Apoptosis by Targeting BCL-2 and Inhibits Tumor Progression in Lung Adenocarcinoma in Vitro and Xenograft Mice Model.

Authors:  Raj Kumar Mongre; Chandra Bhushan Mishra; Amresh Prakash; Samil Jung; Beom Suk Lee; Shikha Kumari; Jin Tae Hong; Myeong-Sok Lee
Journal:  Cancers (Basel)       Date:  2019-08-25       Impact factor: 6.639

7.  Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.

Authors:  Longchuan Wu; Yu Chen; Jiao Yi; Yi Zhuang; Lei Cui; Chunhui Ye
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

8.  Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.

Authors:  A Acharya; R Agarwal; M B Baker; J Baudry; D Bhowmik; S Boehm; K G Byler; S Y Chen; L Coates; C J Cooper; O Demerdash; I Daidone; J D Eblen; S Ellingson; S Forli; J Glaser; J C Gumbart; J Gunnels; O Hernandez; S Irle; D W Kneller; A Kovalevsky; J Larkin; T J Lawrence; S LeGrand; S-H Liu; J C Mitchell; G Park; J M Parks; A Pavlova; L Petridis; D Poole; L Pouchard; A Ramanathan; D M Rogers; D Santos-Martins; A Scheinberg; A Sedova; Y Shen; J C Smith; M D Smith; C Soto; A Tsaris; M Thavappiragasam; A F Tillack; J V Vermaas; V Q Vuong; J Yin; S Yoo; M Zahran; L Zanetti-Polzi
Journal:  J Chem Inf Model       Date:  2020-12-16       Impact factor: 4.956

9.  Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.

Authors:  Rita Afriyie Boateng; Özlem Tastan Bishop; Thommas Mutemi Musyoka
Journal:  Malar J       Date:  2020-11-30       Impact factor: 2.979

10.  Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase.

Authors:  Olivier Sheik Amamuddy; Thommas Mutemi Musyoka; Rita Afriyie Boateng; Sophakama Zabo; Özlem Tastan Bishop
Journal:  Comput Struct Biotechnol J       Date:  2020-05-18       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.